Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1996;27:1903-1909

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alves, W. A.
Right arrow Articles by Macciocchi, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alves, W. A.
Right arrow Articles by Macciocchi, S. N.

(Stroke. 1996;27:1903-1909.)
© 1996 American Heart Association, Inc.


Articles

Ethical Considerations in Clinical Neuroscience

Current Concepts in Neuroclinical Trials

Wayne A. Alves, PhD Stephen N. Macciocchi, PhD

the Department of Neurosurgery and Neuroclinical Trials Center, Virginia Neurological Institute (W.A.A.), and the Departments of Physical Medicine and Rehabilitation and of Psychiatric Medicine (S.N.M.), University of Virginia Medical School (Charlottesville).

Background Ethical decision making in clinical trials has become increasingly emphasized at many levels of the review process.

Summary of Review Ethical concepts applicable to neuroclinical trials are reviewed. The discussion is directed toward ethical concerns that investigators must consider and justify prior to institutional review board submission. Risk-benefit analysis, methodology (randomization, placebo, design), and consent (informed, deferred, waived) are reviewed and guidelines of the Office for Protection From Research Risk are described.

Conclusions Investigators proposing neuroclinical trials face increasing ethical scrutiny by institutional review boards. Attention to ethical issues early in the trial planning process is recommended.


Key Words: clinical trials • ethics, medical • informed consent




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Hofmeijer, G J Amelink, H M den Hertog, A Algra, L J Kappelle, H B van der Worp, and on behalf of the HAMLET and PAIS investigators
Appreciation of the informed consent procedure in a randomised trial of decompressive surgery for space occupying hemispheric infarction
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1124 - 1128.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L R CAPLAN
Evidence based medicine: concerns of a clinical neurologist
J. Neurol. Neurosurg. Psychiatry, November 1, 2001; 71(5): 569 - 574.
[Full Text] [PDF]


Home page
StrokeHome page
H. Slyter
Ethical Challenges in Stroke Research
Stroke, August 1, 1998; 29(8): 1725 - 1729.
[Abstract] [Full Text] [PDF]